CRP1 inhibitors, short for Cysteine-Rich Peptide 1 inhibitors, belong to a distinctive chemical class characterized by their specific targeting of the CRP1 protein. CRP1 is a cysteine-rich peptide found in various biological systems, playing crucial roles in cellular processes. The inhibitors designed to interact with CRP1 possess unique structural features that enable them to bind selectively to the active sites of the CRP1 protein, thereby modulating its function. The chemical architecture of CRP1 inhibitors is intricately designed to establish precise molecular interactions with the target protein, involving key amino acid residues and structural motifs.
CRP1 inhibitors involves disrupting the native conformation of the CRP1 protein, thereby influencing its cellular functions. The inhibitors typically possess functional groups and molecular moieties that facilitate strong binding to specific sites on CRP1, leading to alterations in its three-dimensional structure. This targeted interference can impact downstream signaling pathways and molecular cascades associated with CRP1, influencing cellular responses. The rational design of CRP1 inhibitors is rooted in a deep understanding of the protein's structure-activity relationship, ensuring the specificity and efficacy of the inhibitors in modulating CRP1 function. As researchers continue to explore the intricate details of CRP1 inhibition, this chemical class holds promise for further insights into cellular processes and potential applications in various scientific domains.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which indirectly impacts the MAPK/ERK pathway that can regulate CSRP1 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, altering AKT signaling, potentially affecting pathways regulating CSRP1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, which may alter transcription factors that could interact with CSRP1 expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially affecting stress response pathways linked to CSRP1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, may change skeletal muscle growth and thus indirectly influence CSRP1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, affecting AKT pathway and possibly CSRP1 regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, potentially modifying gene expression including CSRP1. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, could indirectly affect CSRP1 expression by altering methylation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, could alter cytoskeletal dynamics and potentially influence CSRP1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor, could increase protein levels including potentially CSRP1. | ||||||